Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Vera Auchynka"'
Autor:
Vera Auchynka, Ajay M.V. Kumar, Hennadz Hurevich, Yuliia Sereda, Varvara Solodovnikova, Dzmitry Katovich, Svetlana Setkina, Askar Yedilbayev, Aliaksandr Skrahin, Alena Skrahina
Publikováno v:
Monaldi Archives for Chest Disease, Vol 91, Iss 1 (2021)
To address the sub-optimal treatment outcomes among patients with multidrug-resistant (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB), the National TB Programme in Belarus started using new drugs such as bedaquiline and delamanid in 201
Externí odkaz:
https://doaj.org/article/bf448c2529da4c71891fba264ff31239
Autor:
Varvara Solodovnikova, Ajay M.V. Kumar, Hennadz Hurevich, Yuliia Sereda, Vera Auchynka, Dzmitry Katovich, Dzmitry Klimuk, Aliaksandr Skrahin, Svetlana Setkina, Iryna Charnysh, Askar Yedilbayev, Alena Skrahina
Publikováno v:
Monaldi Archives for Chest Disease, Vol 91, Iss 1 (2021)
There is limited evidence describing the safety and effectiveness of bedaquiline and delamanid containing regimens in children and adolescents with Multidrug-Resistant Tuberculosis (MDR-TB) and Extensively Drug-Resistant Tuberculosis (XDR-TB) globall
Externí odkaz:
https://doaj.org/article/61eddf23be564d8bb178f103fce0b2a0
Autor:
Askar Yedilbayev, Dzmitry Katovich, Hennadz Hurevich, Vera Auchynka, Yuliia Sereda, Varvara Solodovnikova, Alena Skrahina, Ajay M. V. Kumar, Aliaksandr Skrahin, Svetlana Setkina
Publikováno v:
Monaldi Archives for Chest Disease, Vol 91, Iss 1 (2021)
To address the sub-optimal treatment outcomes among patients with multidrug-resistant (MDR-TB) and extensively drug-resistant tuberculosis (XDR-TB), the National TB Programme in Belarus started using new drugs such as bedaquiline and delamanid in 201
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b577712fd1e9c304984102c7b8d51d73
https://pubmed.ncbi.nlm.nih.gov/33470081
https://pubmed.ncbi.nlm.nih.gov/33470081
Autor:
Fabrizio Palmieri, Aurora Jazmín Roby Arias, Alena Skrahina, Gina Gualano, Giovanni Sotgiu, Dante Vargas Vasquez, Eduardo Henrique Bonini, Marina Tadolini, Gerard de Vries, Saverio De Lorenzo, Jose A. Caminero, Pietro Viggiani, Marcos Abdo Arbex, Valentina Alarcon Guizado, Apostolos Papavasileiou, Lorena Collahuazo López, Simon Tiberi, Simone Dore, Andrea Piana, Anna Scardigli, Vera Auchynka, Marie-Christine Payen, Antonio Spanevello, Felix Antonio Chong Marin, Alena Aleksa, Edith Alarcon Arrascue, Janina Artsukevich, Heinke Kunst, Alberto Matteelli, Onno W. Akkerman, Giorgia Sulis, Alimuddin Zumla, Giovanni Battista Migliori, Lia D'Ambrosio, Ivan Solovic, Jan-Willem C. Alffenaar, Mina Gaga, Charalampos Moschos, Veronica White, Rosella Centis
Publikováno v:
European Respiratory Journal, 47(6), 1758-1766. EUROPEAN RESPIRATORY SOC JOURNALS LTD
No large study to date has ever evaluated the effectiveness, safety and tolerability of imipenem/clavulanateversusmeropenem/clavulanate to treat multidrug- and extensively drug-resistant tuberculosis (MDR- and XDR-TB). The aim of this observational s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1121bd9795dfefa59b10c158d8e1e4eb
https://research.rug.nl/en/publications/7cd879c6-28f9-4b38-912a-54febdef9981
https://research.rug.nl/en/publications/7cd879c6-28f9-4b38-912a-54febdef9981